EXPLORE!

WHO lists two more COVID-19 vaccines for emergency use and roll-out

  839 Views

eMediNexus    16 February 2021

The World Health Organization (WHO) has authorized two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use.

The vaccines can now be rolled out across the globe through COVAX Facility. The two newly approved vaccines have been manufactured by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

WHO’s Emergency Use Listing (EUL) determines the quality, safety and efficacy of COVID-19 vaccines and is essential for vaccine supply under the COVAX Facility. The EUL enables countries to accelerate their regulatory approval in order to import and administer the vaccines. In this case, WHO looked at the data available on quality, safety and efficacy, as well as risk management plans and cold chain requirements, and the process was complete in less than four weeks… (WHO, February 15, 2021)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.